United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 210,186 | 285,409 | 189,956 | 100,352 | 134,502 |
| Marketable Securities | 251,553 | 94,066 | 103,414 | 129,140 | 100,994 |
| Receivables | 75,569 | 83,514 | 63,510 | 50,626 | 48,968 |
| Inventories | 33,422 | 30,243 | 25,819 | 26,360 | 24,814 |
| Income taxes - deferred | 11,777 | 10,683 | 7,399 | 7,192 | 4,736 |
| Other current assets | 8,285 | 2,985 | 0 | 2,638 | 0 |
| TOTAL | $598,484 | $516,292 | $398,745 | $324,507 | $322,151 |
| Non-Current Assets | |||||
| PPE Net | 303,188 | 302,544 | 304,642 | 303,859 | 299,260 |
| Investments And Advances | 204,438 | 175,473 | 200,760 | 188,604 | 169,300 |
| Other Non-Current Assets | 176,674 | 193,366 | 222,556 | 234,574 | 214,016 |
| TOTAL | $684,300 | $671,383 | $727,958 | $727,037 | $682,576 |
| Total Assets | $1,282,784 | $1,187,675 | $1,126,703 | $1,051,544 | $1,004,727 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 231,932 | N/A | N/A | 220,272 | 216,525 |
| Accounts payable and accrued liabilities | 11,296 | 9,349 | 6,550 | 18,750 | 17,688 |
| Accrued Expenses | 45,542 | 41,889 | 32,635 | 29,764 | 27,000 |
| Other current liabilities | 77,543 | 55,632 | 65,763 | 61,401 | 39,814 |
| TOTAL | $397,465 | $365,724 | $329,038 | $330,187 | $301,027 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 44,588 | 39,650 | 38,817 | 38,021 | 34,086 |
| TOTAL | $44,588 | $39,650 | $69,417 | $68,348 | $64,143 |
| Total Liabilities | $442,053 | $405,374 | $398,455 | $398,535 | $365,170 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,917 | 56,450 | 55,852 | 54,608 | 53,840 |
| Common Shares | 592 | 589 | 581 | 567 | 282 |
| Retained earnings | 21,626 | -18,110 | -55,817 | -74,746 | -71,135 |
| Other shareholders' equity | -6,592 | -7,612 | -6,327 | -4,709 | -4,025 |
| TOTAL | $840,731 | $782,301 | $728,248 | $653,009 | $639,557 |
| Total Liabilities And Equity | $1,282,784 | $1,187,675 | $1,126,703 | $1,051,544 | $1,004,727 |